Benchmark Suggests Buying Bio-Reference Laboratories (BRLI) on Weakness; Robust Trends To Continue
Tweet Send to a Friend
Benchmark maintains a 'Buy' on Bio-Reference Laboratories (NASDAQ: BRLI) price target of $30.00 (from $27.00).
Analyst, Raymond Myers, said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Raymond Myers, said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
